Impact of Prebiopsy Multiparametric Magnetic Resonance Imaging on Prostate Cancer Detection in Switzerland.

ABSTRACT:

Background and objective

Multiparametric magnetic resonance imaging (mpMRI)-guided prostate biopsies have become the standard of care. This study aims to analyze changes in the distribution of detected prostate cancer (PCa) risk groups in Switzerland during the adoption period of a multiparametric magnetic resonance imaging (mpMRI)-guided prostate biopsy.

Methods

This ecological study analyzed prostate biopsies from a tertiary hospital and PCa diagnoses from the National Agency for Cancer Registration in Switzerland between January 2005 and December 2019. A survey assessed mpMRI uptake in Swiss urological centers. PCa risk group proportions were calculated and compared for the entire period and annually.

Key findings and limitations

A total of 4890 biopsies in the hos

SUBMITTER: Scherer TP 

PROVIDER: S-EPMC11804726 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature